Norclozapine

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameNorclozapine
Drug Alias Name去甲氯氮平DesmethylclozapineN-DesmethylclozapineACP-104NDMC
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine D3 receptor agonistsDopamine D2 receptor agonistsSerotonin 2a (5-HT2a) receptor agonists +[4] 
TargetsSerotonin 2a (5-HT2a) receptorMuscarinic acetylcholine receptor M1Dopamine D2 receptor +[4] 
Therapy Area/IndicationsSchizophrenia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAcadia Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity of Texas Southwestern Medical CenterAcadia Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsSchizophrenia

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBank